METASTASIS
Clinical trials for METASTASIS explained in plain language.
Never miss a new study
Get alerted when new METASTASIS trials appear
Sign up with your email to follow new studies for METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug THOR-707 tested in patients with advanced tumors
Disease control TerminatedThis study tested an experimental drug called THOR-707 in adults with advanced solid tumors that had spread. The goal was to find safe doses and see if the drug could shrink tumors when used alone or with other treatments. The study was stopped early, so results are limited.
Matched conditions: METASTASIS
Phase: PHASE1, PHASE2 • Sponsor: Synthorx, Inc, a Sanofi company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New MRI dye could spot hidden prostate cancer cells
Diagnosis TerminatedThis phase 3 trial tested whether an iron-based contrast agent called Ferumoxtran-10 (Ferrotran®) could improve MRI scans to find prostate cancer that has spread to lymph nodes. The study involved 172 men with newly diagnosed prostate cancer at intermediate to high risk of spread…
Matched conditions: METASTASIS
Phase: PHASE3 • Sponsor: Saving Patients' Lives Medical B.V. • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Brain radiation for breast cancer: prevention study halted early
Prevention TerminatedThis study looked at whether giving radiation to the brain could prevent cancer from spreading there in people with HER2-positive breast cancer that had already spread to other organs. Participants were receiving trastuzumab (Herceptin) plus chemotherapy. The study was stopped ea…
Matched conditions: METASTASIS
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC